|
SNRNP40 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.39689999859527E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.91569998437325E-09 |
| Normal-vs-Stage2 |
3.97920000000385E-05 |
| Normal-vs-Stage3 |
1.08210000004938E-06 |
| Normal-vs-Stage4 |
3.48640000003009E-06 |
| Stage1-vs-Stage2 |
9.610200E-01 |
| Stage1-vs-Stage3 |
7.114400E-01 |
| Stage1-vs-Stage4 |
2.443200E-01 |
| Stage2-vs-Stage3 |
8.379000E-01 |
| Stage2-vs-Stage4 |
4.088800E-01 |
| Stage3-vs-Stage4 |
2.917200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.94680000295844E-08 |
| Normal-vs-AfricanAmerican |
4.57459625735623E-11 |
| Normal-vs-Asian |
5.552500E-04 |
| Caucasian-vs-AfricanAmerican |
1.202770E-01 |
| Caucasian-vs-Asian |
4.790400E-01 |
| AfricanAmerican-vs-Asian |
6.467600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.09240000273547E-09 |
| Normal-vs-Female |
5.786300E-04 |
| Male-vs-Female |
6.257700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.18609999599784E-08 |
| Normal-vs-Extreme_Weight |
1.25330001932156E-09 |
| Normal-vs-Obese |
1.74789999995983E-06 |
| Normal-vs-Extreme_Obese |
3.84770000000367E-05 |
| Normal_Weight-vs-Extreme_Weight |
9.814000E-01 |
| Normal_Weight-vs-Obese |
4.931600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.113600E-01 |
| Extreme_Weight-vs-Obese |
4.089000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.264000E-01 |
| Obese-vs-Extreme_Obese |
4.205400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.164790E-04 |
| Normal-vs-Age(41-60Yrs) |
1.50829999601143E-08 |
| Normal-vs-Age(61-80Yrs) |
6.13770000379432E-08 |
| Normal-vs-Age(81-100Yrs) |
2.08329999995538E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.447800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.323800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.119160E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.630800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.600000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.432200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.17229999941193E-08 |
| Normal-VS-Type2 PRCC |
1.56770000314665E-08 |
| Normal-VS-KIRP CIMP |
6.477500E-03 |
| Normal-VS-Unclassified PRCC |
3.65020000000493E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.831600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.841200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.627600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.992360E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.423400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.800600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.70750097289374E-11 |
| Normal-vs-N1 |
1.629570E-02 |
| Normal-vs-N2 |
5.261500E-03 |
| N0-vs-N1 |
1.222010E-01 |
| N0-vs-N2 |
9.750800E-01 |
| N1-vs-N2 |
5.270000E-01 |
|
|
